First Patient Receives Gene Therapy for Rare Liver Disorder
Вставка
- Опубліковано 15 вер 2024
- An investigational gene therapy for glycogen storage disease (GSD) was administered to a patient for the first time ever on July 24. Dr. David Weinstein and his team administered the one-time, 30-minute infusion at UConn John Dempsey Hospital. The gene therapy gives real hope to patients who suffer from the potentially deadly GSD - a rare childhood genetic disorder impacting the liver’s storage and release of sugar. Watch the video to meet Jerrod and see him receive this groundbreaking therapy.
Prayers for success!! My great Niece and Nephew both have GSD.
2020 any news please !
You got it jerrod🤙I’m here for you bro
Your a true hero. My daughter has gsd.
I love you a miracle is happening your sister Daisy Cammack
Gerica Cammick loo I P.O.l l.p. lil I o li